Bio-Rad Laboratories BIO
NYSE BIO
$379.03 -1.09 (-0.29%)
As of: Sep 9, 2026 · 2:33 PM EDT

Bio-Rad Laboratories (BIO) Operating Margin Growth (1y) (2010 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Operating Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 225.11 Bn 221.05 Bn 8.34 Bn 50.00
2 Danaher 144.81 Bn 140.46 Bn 3.61 Bn 519.00
3 Agilent Technologies 41.10 Bn 39.34 Bn 1.04 Bn 293.00
4 Illumina 31.33 Bn 30.16 Bn 770.00 Mn 93.00
5 Revvity 13.87 Bn 12.84 Bn 416.87 Mn -36.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 3,065.00
7 Bio-Rad Laboratories 10.14 Bn 8.52 Bn 345.80 Mn -68.00
8 Repligen 9.32 Bn 8.31 Bn 110.04 Mn -77.00
9 10x Genomics 8.66 Bn 8.11 Bn 112.50 Mn -3,037.00
10 Bruker 8.29 Bn 8.08 Bn 416.00 Mn -928.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -68.00
Mar 31, 2026 171.00
Dec 31, 2025 -2,589.00
Sep 30, 2025 7.00
Jun 30, 2025 -406.00
Mar 31, 2025 -325.00
Dec 31, 2024 -526.00
Sep 30, 2024 -446.00
Jun 30, 2024 274.00
Mar 31, 2024 -185.00
Dec 31, 2023 -225.00
Sep 30, 2023 49.00
Jun 30, 2023 -462.00
Mar 31, 2023 -1,176.00
Dec 31, 2022 16.00
Sep 30, 2022 -709.00
Jun 30, 2022 35.00
Mar 31, 2022 703.00
Dec 31, 2021 -741.00
Sep 30, 2021 406.00